Morning Overview on MSN
How science and luck sparked a radical new era in schizophrenia treatment
The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...
LOS ANGELES — The novel phosphodiesterase 10A (PDE10A) inhibitor known as CPL'36 (Celon Pharma) is effective and generally safe in acute exacerbations of schizophrenia, new research suggested. In a ...
Significant side effects of this medication include extrapyramidal symptoms, or involuntary movements and muscle stiffness, which can lead to motor deficits like those seen in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results